Medicaid's Expenditures for Newer Pharmacotherapies for Adults with Disabilities
View/
Issue Date
2007-06-01Article Version
Scholarly/refereed, publisher version
Published Version
https://www.cms.gov/Research-Statistics-Data-and-Systems/Research/HealthCareFinancingReview/downloads/07Summerpg31.pdfMetadata
Show full item recordAbstract
Medicaid's drug expenditures have grown at double-digit inflation rates since 2000. These prescription drug costs are important contributors to increasing health care costs for disabled persons. In spite of this knowledge, little has been reported about specific patterns of medication use among disabled enrollees. We analyzed Kansas Medicaid data to describe trends in medication use patterns across 3 years among disabled beneficiaries.
Description
This is the publisher's version, also available electronically from http://www.cms.gov/Research-Statistics-Data-and-Systems/Research/HealthCareFinancingReview/List-of-Past-Articles-Items/CMS1206484.html?DLPage=1&DLFilter=2007&DLSort=2&DLSortDir=descending.
ISSN
0195-8631Collections
Citation
Shireman, Theresa I.; Hall, Jean P.; Rigler, Sally K.; Moore, Janice M. 2007. "Medicaid's Expenditures for Newer Pharmacotherapies for Adults with Disabilities." Health Care Financing Review, 28(4):31-42.
Items in KU ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
